Beirne Wealth Consulting Services, LLC Johnson & Johnson Transaction History

Beirne Wealth Consulting Services, LLC

$248 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$145.6 - $158.88 $102,356 - $111,692	703 Added 41.52%	2,396 $376 Million
Q1 2023 May 10, 2023	BUY	$151.05 - $180.26 $14,047 - $16,764	93 Added 5.81%	1,693 $262 Million
Q4 2022 Feb 08, 2023	SELL	$160.2 - $179.79 $4,004 - $4,494	-25 Reduced 1.54%	1,600 $282,000
Q3 2022 Nov 07, 2022	SELL	$161.33 - $179.52 $6,453 - $7,180	-40 Reduced 2.4%	1,625 $265,000
Q2 2022 Jul 13, 2022	SELL	$168.19 - $186.01 $4,204 - $4,650	-25 Reduced 1.48%	1,665 $296,000
Q4 2021 Feb 03, 2022	SELL	$155.93 - $173.01 $31,186 - $34,602	-200 Reduced 10.58%	1,690 $289,000
Q3 2021 Nov 09, 2021	SELL	$161.5 - $179.47 $8,559 - $9,511	-53 Reduced 2.73%	1,890 $303,000
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $1,594 - $1,710	-10 Reduced 0.51%	1,943 $321,000
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $305,986 - $340,789	-1,999 Reduced 50.58%	1,953 $321,000
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $822 - $944	6 Added 0.15%	3,952 $622,000
Q3 2020 Nov 05, 2020	BUY	$140.38 - $153.83 $353,476 - $387,343	2,518 Added 176.33%	3,946 $588,000
Q2 2020 Jul 31, 2020	SELL	$128.81 - $155.51 $37,354 - $45,097	-290 Reduced 16.88%	1,428 $201,000
Q1 2020 Apr 28, 2020	BUY	$111.14 - $153.99 $2,445 - $3,387	22 Added 1.3%	1,718 $225,000
Q4 2019 Jan 14, 2020	SELL	$127.5 - $146.44 $228,862 - $262,859	-1,795 Reduced 51.42%	1,696 $247,000
Q2 2019 Jul 25, 2019	SELL	$131.15 - $144.24 $411,942 - $453,057	-3,141 Reduced 47.36%	3,491 $486,000
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $21,120 - $23,484	-168 Reduced 2.47%	6,632 $927,000
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $835,312 - $1.01 Million	6,800 New	6,800 $878,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.

Account